Arantxa Roca-Feltrer, PhD, PATH, Mozambique
Busiku Hamainza, PhD, Ministry of Health, Zambia
Malaria Journal is announcing this invite only collection on the RTS,S/AS01 Malaria Vaccine Implementation Programme in Ghana, Kenya and Malawi. For more information refer to About the collection below.
Image credit: WHO/Fanjan Combrink
This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.
Arantxa Roca-Feltrer, PhD, PATH, Mozambique
Dr. Arantxa Roca-Feltrer is a PhD malaria epidemiologist trained at the London School of Hygiene and Tropical Medicine (LSHTM) with over 20 years of experience in both malaria control and malaria elimination countries from the African and Asian regions. From 2012 to 2016 Doctor Roca-Feltrer supported malaria elimination efforts in the Greater Mekong Subregion (GMS). As part of her current position as Regional Malaria Director at PATH, she contributes to supporting global strategic policies, approaches and priorities for Surveillance as well as M&E strategies within the malaria control to elimination spectrum to the regions and country offices. She is currently based in Mozambique since 2018 where she leads surveillance strengthening initiatives in the region.
Busiku Hamainza, PhD, Ministry of Health, ZambiaDr. Busiku Hamainza is a seasoned public health expert with over two decades of experience, specializing in malaria epidemiology and global health management. With a PhD in Tropical Medicine from the Liverpool School of Tropical Medicine, BH has led national efforts in Zambia to combat malaria, HIV, and TB through various leadership roles, including Acting Director at the National Malaria Elimination Centre and current Grants Coordinator at the Ministry of Health. BH is skilled in program management, disease surveillance, capacity building and health systems strengthening, and is committed to advancing public health through evidence-based research and policy.
Malaria Journal is announcing this invite only collection on the RTS,S/AS01 malaria vaccine implementation programme in Ghana, Kenya and Malawi.
As of October 2023, WHO recommends the programmatic use of malaria vaccines for the prevention of P. falciparum malaria in children living in malaria endemic areas, prioritizing areas of moderate and high transmission. This applies to both RTS,S/AS01 and R21/Matrix-M vaccines.
The first malaria vaccine, RTS,S, was recommended by WHO to prevent malaria in children in October 2021. The vaccine has reached nearly 2 million children in Ghana, Kenya and Malawi through the Malaria Vaccine Implementation Programme, MVIP, since 2019.
Reference: WHO Malaria Vaccination Impementation Programme
Image credit: WHO/Fanjan Combrink
There are currently no articles in this collection.
This Collection welcomes submission of research articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “The RTS,S/AS01 Malaria Vaccine Implementation Programme in Ghana, Kenya and Malawi" under the “Details” tab during the submission stage.
Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.